Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Douglas Taylor currently holds 2,354 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Douglas Taylor has been a net seller of DCPH stock. They have purchased $0 and sold $34.9M worth of shares.
Michael Douglas Taylor's most recent insider trade was on May 3, 2021, when they sold 2,354 shares at $1.89 per share.
Michael Douglas Taylor serves as Executive at Deciphera Pharmaceuticals, Inc. (DCPH). They have executed 98 insider transactions totaling $34.9M over their tenure at the company.
Michael Douglas Taylor holds the position of Executive at Deciphera Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Michael Douglas Taylor has shown a selling trading pattern, with $0 in total purchases and $34.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Douglas Taylor was on Oct 1, 2020, when they sold $5.2M worth of DCPH shares. This transaction involved 101,114 shares at $51.52 per share.
Michael Douglas Taylor currently owns 2,354 shares of Deciphera Pharmaceuticals, Inc. (DCPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Douglas Taylor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Douglas Taylor has 98 Form 4 filings on record as an insider at Deciphera Pharmaceuticals, Inc..
Set alerts for Michael Douglas Taylor and 40,000+ other insiders.